- Child cancer groups call for concerted action
- Experimental study points to systemic sclerosis treatment
- Protein build-up may shape cancer drug response
- Sanofi and Cheplapharm to create new strategic partnership in mature medicines
- Hidden immune cells in the lung could lead to better flu vaccines
- Novel drug shows promise in an early phase trial in heart failure
- Cholesterol-lowering medication reduces heart attack and stroke risk in older people by 30%
- Scientists decode gene circuits of human immunity, fueling new era of disease research
- FDA approves first in class targeted therapy for metastatic pancreatic cancer
- Rethinking oral cancer treatment: A review of next-generation drug delivery systems
- AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries
- A ray of hope in the fight against cancer
- FDA approves first drug of its kind for polycythemia vera, a rare blood disorder
- Novel combination therapy improves treatment outcomes in preclinical lung cancer models
- First-in-class therapy targets "undruggable" protein in hard-to-treat blood cancers
- AI designs a novel E. coli killer
- GLP-1 drug linked to heart benefits for high-risk patients
- FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber
- Targeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance
- Engineered human neurons rebuild damaged spinal cord circuits
Website: https://www.worldpharmanews.com/
